Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo-Reference-Cited by-同舟云学术

Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo

Published:2006-07-24 Issue:6 Volume:26 Page:905-916
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Morales A,París R,Villanueva A,Llacuna L,García-Ruiz C,Fernández-Checa J C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1209834.pdf

Reference46 articles.

1. Bielawska A, Greenberg MS, Perry D, Jayadev S, Shayman JA, McKay C et al. (1996). (1S, 2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J Biol Chem 271: 12646–12654.

2. Birbes H, El Bawab S, Hannun YA, Obeid LM . (2001). Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J 15: 2669–2679.

3. Block TM, Mehta AS, Fimmel CJ, Jordan R . (2003). Molecular viral oncology of hepatocellular carcinoma. Oncogene 22: 5093–5107.

4. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R . (1995). Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82: 405–414.

5. Burek C, Roth J, Koch HG, Harzer K, Los M, Schulze-Osthoff K . (2001). The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene 20: 6493–6502.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma;Current Drug Delivery;2024-05-02

2. Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells;Cancers;2023-09-20

3. Genetics of enzymatic dysfunctions in metabolic disorders and cancer;Frontiers in Oncology;2023-08-02

4. Sphingolipid Metabolism in Cancer: Potential Therapeutic Target;Handbook of Cancer and Immunology;2023

5. Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma;Journal of Nanobiotechnology;2022-09-29